KFDA announces post-surveillance results of 86 medicines

Published: 2012-04-20 06:59:00

Updated: 2012-04-20 06:59:00

The Korea Food and Drug Administration has recently issued updated recommendations concerning adverse events of 86 drugs based on their post-surveillance results over the past 6 years.

According to the safety announcement, the incidence rate of adverse events in 1,235 patients receiving metfor...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK